Menu
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Leica Biosystems News & Events

DELIVERING GREATER THROUGHPUT AND DECREASED TURNAROUND TIME FOR RESEARCH LABS IS THE FOCUS OF LEICA BIOSYSTEMS NEXT GENERATION DIGITAL PATHOLOGY SCANNER

Published:
VISTA, CA – Aug 9, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only,...

5th Digital Pathology & AI Congress: USA

Published:
Come visit Leica Biosystems at the 5th Digital Pathology & AI Congress: USA booth #13 and learn more about our Imaging Solutions portfolio in hardware and software.

Leica Biosystems Receives FDA 510(k) Clearance to Market a Digital Pathology System for Primary Diagnosis

Published:
VISTA, CA –May 29, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the...

Pathology Informatics May 7-8 2019, Pittsburgh, Pennsylvania

Published:
Come visit Leica Biosystems at our Patho Informatics booth #Gold 1 and learn more about our Aperio imaging solutions portfolio.

Leica Biosystems Receives US Patent for RTF Extreme Speed Scanning Technology

Published:
VISTA, CA – January 7th, 2019 – Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has granted it a patent for RTF, its breakthrough “Real-Time Focusing” technology (US patent 9,841,590)....

Multiplex fluorescence immunohistochemistry using the Ultivue InSituPlex platform on the Leica Biosystems BOND RX

Published:
Register Now for On Demand Abstract: Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the analysis of target protein expression in subsets of specific cells within the context of...

A new PD-L1 BOND-Ready-to-Use antibody, providing you with the freedom and flexibility to develop the tests you need

Published:
NEWCASTLE, ENGLAND, UK NOVEMBER 2018 – Leica Biosystems, a leading provider of pathology products and solutions, globally launched a new PD-L1 antibody for use on their fully automated BOND IHC and ISH staining platform. The new PD-L1 (programmed...

Unlocking the complexities of cancer biology with BOND RX and Ultivue.

Published:
Melbourne, Australia and Cambridge, Massachusetts – September 14, 2018 | Leica Biosystems and Ultivue begin Co-Marketing of UltiMapper™ Assay on the BOND RX enabling single-step automated multiplexing in under 6 hours. Building on its legacy of...

Partnership of Leeds Teaching Hospitals NHS Trust with Leica Biosystems Achieves Major Milestone for Cancer Diagnostics

Published:
Collaboration to enable large-scale transition from glass slides to digital images for pathology diagnoses across all subspecialties VISTA, Calif.—Oct. 11, 2018— Leica Biosystems the cancer diagnostics leader achieved a major digital pathology...

For Breast Biopsies, MammoPort Standardizes Tissue Transfer from Radiology to Pathology to Ensure Quality and Reduce Errors

Published:
New from Leica Biosystems, first integrated specimen containment and transport system promises to enhance efficiency and diagnostic confidence. RICHMOND, Ill.— October 2, 2018 — Leica Biosystems, the leader in cancer diagnostics from biopsy to...